Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Olmesartan Medoxomil in Hypertension and Renal Impairment
This study has been completed.
Study NCT00151827 Information provided by Daiichi Sankyo Inc.
First Received: September 8, 2005 Last Updated: October 11, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Essential Hypertension
Renal Impairment
Additional conditions recognized in this trial
Hypertension
More general conditions related to this trial
Cardiovascular Diseases
Vascular Diseases
Interventions listed in this trial
Olmesartan medoxomil
Losartan
Furosemide
More general drug interventions related to this trial
Angiotensin II Type 1 Receptor Blockers
Anti-Arrhythmia Agents
Antihypertensive Agents
Cardiovascular Agents
Diuretics
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sodium Potassium Chloride Symporter Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Sankyo Pharma Gmbh
Back to top of Main Content